•  
  •  
  •  
  •  

2026-07-20 05:25:58

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million

Keywords Selected:  DCGI

Stock Report

  • Wockhardt files fast-acting Insulin Aspart injection with DCGI
  • AstraZeneca Pharma India Ltd receives permission from DCGI for Dapagliflozin Tablets 10 mg
  • ICICI Prudential Life Insurance Company Ltd receives demand notice from DCGI for Rs. 492.06 crores
  • Themis Medicare announces DCGI approval of Remifentanil Hydrochloride 1mg/2mg for injection for import and marketing
  • AstraZeneca Pharma India gets permission from DCGI for Olaparib Film-Coated tablets
  • Themis Medicare Ltd gets add on approval for drug VIRALEX®
  • ZyCoV-D® as a two-dose vaccine receives EUA from DCGI
  • Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical Trial of its Novel Molecule GRC 54276
  • Zydus to launch Oxemia™ a breakthrough treatment for Anemia in patients suffering from CKD
  • DCGI approves Themis Medicare's VIRALEX® for Covid-19 treatment
  • Aurobindo announces DCGI's permission to manufacture and market its generic version of Molnupiravir
  • Strides receives DCGI approval under EUA to commercialize Molnupiravir
  • Sun Pharma receives DCGI approval for Molxvir® in India
  • Cipla receives EUA to launch oral antiviral drug Cipmolnu® in India
  • Zydus develops new treatment for patients suffering from Chronic Kidney Disease

Latest Post

  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025